Efficacy and safety of osilodrostat in patients with Cushing's disease (LINC 3): a multicentre phase III study with a double-blind, randomised withdrawal phase
Rosario Pivonello, Maria Fleseriu, John Newell‐Price, Xavier Bertagna, James W. Findling, Akira Shimatsu, Feng Gu, Richard J. Auchus, Rattana Leelawattana, Eun Jig Lee, Jung Hee Kim, André Lacroix, Audrey Laplanche, P.R. O'Connell, Libuse Tauchmanovà, Alberto M Pedroncelli, Beverly M. K. Biller
Topics & Concepts
MedicineCushing's diseaseInternal medicineClinical trialGastroenterologySurgeryDiseasePituitary Gland Disorders and TreatmentsAdrenal Hormones and DisordersGrowth Hormone and Insulin-like Growth Factors